Anna Dąbrowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna Dąbrowska has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Perdyan
P-Medicine Laboratory, Medical University of Gdansk, Gdansk, Poland
2 shared publications - Amar Balihodzic
Division of Oncology, Department of Internal Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, 8036 Graz, Austria
2 shared publications - Bartosz Kamil Sobocki
Student Scientific Circle of Oncology and Radiotherapy, Medical University of Gdansk, 80-210 Gdansk, Poland
2 shared publications - Ewa Otręba
Medical University of Gdansk
2 shared publications - Julia Świechowska
Uniwersyteckie Centrum Kliniczne w Gdańsku, Gdańsk, Poland
2 shared publications - JęDrzej Czmyr
University Clinical Center of the Medical University of Warsaw, Warsaw, Poland
2 shared publications
Latest Publications
- Open Access
- 9 July 2024
- Published by Springer Nature in Cureus
- Vol. 16 (7) , e64132
Evaluation of Current and Future Medical Staff Knowledge on the Course of Trauma Patient Management
Introduction: Management of injuries, especially in life-threatening situations, is critical to morbidity and mortality for trauma patients. The qualifications of medical staff and students in medicine, emergency medical services, and nursing help to ensure consistent, high-quality care for patients. The study aimed to assess the knowledge of our staff and learners in the management of trauma patients. Material and methods: The study was carried out using a proprietary research tool consisting of 47 questions, including six independent variables. The knowledge assessment tool has been divided into five categories according to the degree of difficulty. The questions have been created based on the current guidelines of the ERC 2021, ITLS, PTLS, and TCCC. Results: The study included 295 subjects (medical students, nursing students, students of emergency medical services, physicians, paramedics, and nurses). The vast majority of respondents (79.7%) have never participated in a certified trauma course. Respondents could obtain a total of 117 points for answering all questions. The highest score was 111 points, and the lowest was 26 points. The average score was 63 points. Paramedics received the highest average score of 78 points. The question with the smallest number of correct answers concerned the priority procedure in the case of an electric shock victim. Conclusion: Better training in trauma patient management is needed for both current medical staff and students. A certified trauma course is a good source of knowledge and skills, but it would need to be repeated periodically. This would ensure an increase in the competence of medical staff involved in the care of trauma patients.
- 9 July 2024
- Published by Springer Nature in Cureus
- Vol. 16 (7) , e64132
Open AccessEvaluation of Current and Future Medical Staff Knowledge on the Course of Trauma Patient Management
Introduction: Management of injuries, especially in life-threatening situations, is critical to morbidity and mortality for trauma patients. The qualifications of medical staff and students in medicine, emergency medical services, and nursing help to ensure consistent, high-quality care for patients. The study aimed to assess the knowledge of our staff and learners in the management of trauma patients. Material and methods: The study was carried out using a proprietary research tool consisting of 47 questions, including six independent variables. The knowledge assessment tool has been divided into five categories according to the degree of difficulty. The questions have been created based on the current guidelines of the ERC 2021, ITLS, PTLS, and TCCC. Results: The study included 295 subjects (medical students, nursing students, students of emergency medical services, physicians, paramedics, and nurses). The vast majority of respondents (79.7%) have never participated in a certified trauma course. Respondents could obtain a total of 117 points for answering all questions. The highest score was 111 points, and the lowest was 26 points. The average score was 63 points. Paramedics received the highest average score of 78 points. The question with the smallest number of correct answers concerned the priority procedure in the case of an electric shock victim. Conclusion: Better training in trauma patient management is needed for both current medical staff and students. A certified trauma course is a good source of knowledge and skills, but it would need to be repeated periodically. This would ensure an increase in the competence of medical staff involved in the care of trauma patients.
- Open Access
- 4 January 2024
- Published by VM Media Group sp. z o.o in Nowotwory. Journal of Oncology
Management of cervical cancer during pregnancy – a systematic review
Diagnosis of neoplasms during pregnancy and establishing a treatment schedule that is safe for both mother and fetus is problematic. This review summarizes knowledge about the problems associated with cervical cancer during pregnancy and current recommendations for diagnosis and treatment. The systematic review was performed according to PRISMA guidelines. The search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Seven articles on 317 pregnant women with cervical cancer were included. Stage of disease, gestational age at diagnosis, treatment in pregnancy, type of delivery, gestational age of delivery, treatment after delivery, follow-up and main conclusion were analyzed. The rare phenomenon of neoplasms during pregnancy, as well as a limited research, do not allow for the development of clear guidelines for the treatment of cervical cancer in pregnant women. It is warrant to address discussed problems in future clinical research to provide the best care for pregnant cancer patients. Diagnosis of neoplasms during pregnancy and establishing a treatment schedule that is safe for both mother and fetus is problematic. This review summarizes knowledge about the problems associated with cervical cancer during pregnancy and current recommendations for diagnosis and treatment. The systematic review was performed according to PRISMA guidelines. The search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Seven articles on 317 pregnant women with cervical cancer were included. Stage of disease, gestational age at diagnosis, treatment in pregnancy, type of delivery, gestational age of delivery, treatment after delivery, follow-up and main conclusion were analyzed. The rare phenomenon of neoplasms during pregnancy, as well as a limited research, do not allow for the development of clear guidelines for the treatment of cervical cancer in pregnant women. It is warrant to address discussed problems in future clinical research to provide the best care for pregnant cancer patients.
- 4 January 2024
- Published by VM Media Group sp. z o.o in Nowotwory. Journal of Oncology
Open AccessManagement of cervical cancer during pregnancy – a systematic review
Diagnosis of neoplasms during pregnancy and establishing a treatment schedule that is safe for both mother and fetus is problematic. This review summarizes knowledge about the problems associated with cervical cancer during pregnancy and current recommendations for diagnosis and treatment. The systematic review was performed according to PRISMA guidelines. The search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Seven articles on 317 pregnant women with cervical cancer were included. Stage of disease, gestational age at diagnosis, treatment in pregnancy, type of delivery, gestational age of delivery, treatment after delivery, follow-up and main conclusion were analyzed. The rare phenomenon of neoplasms during pregnancy, as well as a limited research, do not allow for the development of clear guidelines for the treatment of cervical cancer in pregnant women. It is warrant to address discussed problems in future clinical research to provide the best care for pregnant cancer patients. Diagnosis of neoplasms during pregnancy and establishing a treatment schedule that is safe for both mother and fetus is problematic. This review summarizes knowledge about the problems associated with cervical cancer during pregnancy and current recommendations for diagnosis and treatment. The systematic review was performed according to PRISMA guidelines. The search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Seven articles on 317 pregnant women with cervical cancer were included. Stage of disease, gestational age at diagnosis, treatment in pregnancy, type of delivery, gestational age of delivery, treatment after delivery, follow-up and main conclusion were analyzed. The rare phenomenon of neoplasms during pregnancy, as well as a limited research, do not allow for the development of clear guidelines for the treatment of cervical cancer in pregnant women. It is warrant to address discussed problems in future clinical research to provide the best care for pregnant cancer patients.
- Open Access
- 14 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 14114
The Role of Regulatory T Cells in Cancer Treatment Resistance
Despite tremendous progress in cancer treatment in recent years, treatment resistance is still a major challenge for a great number of patients. One of the main causes is regulatory T lymphocytes (Tregs), which suppress excessive inflammatory responses via the secretion of immunosuppressive cytokines and upregulate the immune checkpoints. Their abundance causes an immunosuppressive reprogramming of the tumor environment, which is ideal for tumor growth and drug inefficiency. Hence, regiments that can regain tumor immunogenicity are a promising strategy to overcome Tregs-mediated drug resistance. However, to develop effective therapeutic regimens, it is essential to understand the molecular mechanisms of Treg-mediated resistance. In this article, we gathered a comprehensive summary of the current knowledge on molecular mechanisms and the role of Tregs in cancer treatment resistance, including cancer immunotherapy, targeted therapy, chemotherapy, and radiotherapy.
- 14 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 14114
Open AccessThe Role of Regulatory T Cells in Cancer Treatment Resistance
Despite tremendous progress in cancer treatment in recent years, treatment resistance is still a major challenge for a great number of patients. One of the main causes is regulatory T lymphocytes (Tregs), which suppress excessive inflammatory responses via the secretion of immunosuppressive cytokines and upregulate the immune checkpoints. Their abundance causes an immunosuppressive reprogramming of the tumor environment, which is ideal for tumor growth and drug inefficiency. Hence, regiments that can regain tumor immunogenicity are a promising strategy to overcome Tregs-mediated drug resistance. However, to develop effective therapeutic regimens, it is essential to understand the molecular mechanisms of Treg-mediated resistance. In this article, we gathered a comprehensive summary of the current knowledge on molecular mechanisms and the role of Tregs in cancer treatment resistance, including cancer immunotherapy, targeted therapy, chemotherapy, and radiotherapy.
- Open Access
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review
Despite a great success of immunotherapy in cancer treatment, a great number of patients will become resistant. This review summarizes recent reports on immune checkpoint inhibitor retreatment or rechallenge in order to overcome primary resistance. The systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The search was performed using PubMed, Web of Science and Scopus. In total, 31 articles were included with a total of 812 patients. There were 16 retreatment studies and 13 rechallenge studies. We identified 15 studies in which at least one parameter (overall response rate or disease control rate) improved or was stable at secondary treatment. Interval treatment, primary response to and the cause of cessation for the first immune checkpoint inhibitors seem to be promising predictors of secondary response. However, high heterogeneity of investigated cohorts and lack of reporting guidelines are limiting factors for current in-depth analysis.
Open AccessThe Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review
Despite a great success of immunotherapy in cancer treatment, a great number of patients will become resistant. This review summarizes recent reports on immune checkpoint inhibitor retreatment or rechallenge in order to overcome primary resistance. The systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The search was performed using PubMed, Web of Science and Scopus. In total, 31 articles were included with a total of 812 patients. There were 16 retreatment studies and 13 rechallenge studies. We identified 15 studies in which at least one parameter (overall response rate or disease control rate) improved or was stable at secondary treatment. Interval treatment, primary response to and the cause of cessation for the first immune checkpoint inhibitors seem to be promising predictors of secondary response. However, high heterogeneity of investigated cohorts and lack of reporting guidelines are limiting factors for current in-depth analysis.
- Open Access
- 23 May 2023
- Published by Institute of Rural Health in Medycyna Ogólna i Nauki o Zdrowiu
Patients’ preferences – evaluation of teleconsultations during the COVID-19 pandemic
Introduction and objective: The COVID-19 pandemic caused necessary changes to the health care system in terms of the organization and treatment of patients. Remote forms of medical consultations were widely introduced to minimize the risk of viral transmission. The aim of the study was to...
- 23 May 2023
- Published by Institute of Rural Health in Medycyna Ogólna i Nauki o Zdrowiu
Open AccessPatients’ preferences – evaluation of teleconsultations during the COVID-19 pandemic
Introduction and objective: The COVID-19 pandemic caused necessary changes to the health care system in terms of the organization and treatment of patients. Remote forms of medical consultations were widely introduced to minimize the risk of viral transmission. The aim of the study was to...
- Open Access
- 1 January 2022
- Published by Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego in Zdrowie Publiczne i Zarządzanie
- Vol. 20 (3) , 73-80
Patients’ preferences: Comparing the quality of medical services before and during the COVID-19 pandemic
During the COVID-19 pandemic, an increasing number of infections and a need for medical consultations forced the society to implement remote forms of contact with patients. The aim of this study was to analyze the experiences and preferences of patients regarding the doctor-patient relationship. A quantitative study was conducted using the CAWI technique. The study involved 1011 adult patients who were consulted by their family physicians. The patients generally declared unfavorable changes regarding their access to medical services. While comparing the experiences before and during the pandemic, most patients (70.3%) revealed that they had difficulties accessing their family physicians. Many patients (83.1%) preferred a personal visit as a form of consultation. Identification of the constraints relating to the COVID-19 pandemic can contribute to optimizing the health care system, particularly the organization of remote medical consultations.
- 1 January 2022
- Published by Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego in Zdrowie Publiczne i Zarządzanie
- Vol. 20 (3) , 73-80
Open AccessPatients’ preferences: Comparing the quality of medical services before and during the COVID-19 pandemic
During the COVID-19 pandemic, an increasing number of infections and a need for medical consultations forced the society to implement remote forms of contact with patients. The aim of this study was to analyze the experiences and preferences of patients regarding the doctor-patient relationship. A quantitative study was conducted using the CAWI technique. The study involved 1011 adult patients who were consulted by their family physicians. The patients generally declared unfavorable changes regarding their access to medical services. While comparing the experiences before and during the pandemic, most patients (70.3%) revealed that they had difficulties accessing their family physicians. Many patients (83.1%) preferred a personal visit as a form of consultation. Identification of the constraints relating to the COVID-19 pandemic can contribute to optimizing the health care system, particularly the organization of remote medical consultations.
- Open Access
- 16 September 2020
- Published by VM Media Group sp. z o.o in Acta Haematologica Polonica
- Vol. 51 (3) , 164-171
Acute non-hematological toxicity of intensive chemotherapy of acute lymphoblastic leukemia in children
Introduction: Leukemia belong to 31% of all childhood malignancies. Acute lymphoblastic leukemia (ALL) is the most frequent type of pediatric leukemia accounting for 80–85% of all cases. Progress in diagnostics and therapy of leukemia is dependent on international cooperation. The objective of the study was the analysis of non-hematological toxicity during intensive chemotherapy according to two consecutive intercontinental protocols.Patients and methods: A total number of 210 children diagnosed for ALL who were treated in single center between 2002 and 2018 were divided in two groups defined by therapeutic protocol: ALL IC-BFM 2002 (group 1) and ALL IC-BFM 2009 (group 2). Data were entered prospectively from 2002 into international ALL IC-BFM 2002 and ALL IC-BFM 2009 registry. Non-hematological toxicity was analyzed according to the criteria followed in protocols, compatible with CTCAE criteria.Results: The most frequent toxicities included hepatic toxicity with transaminitis and hyperbilirubinemia, infections, oral mucositis and gut toxicity with vomiting, and/or diarrhea. Non-hematological toxicity episodes calculated as a ratio per patient were comparably often observed in both the groups; however, the distribution was different. There were more grade III and less grade II toxicities. This was mainly related to significant increase in the rates of infections and transaminitis. However, there was a significant decrease in vomiting and central and peripheral neurotoxicity.Conclusions: Intensive treatment of ALL is burdened with frequent severe toxic and infectious complications. Further progress in therapy of pediatric ALL is dependent on sophisticated supportive therapy and very well experienced and knowledgeable therapeutic team.
- 16 September 2020
- Published by VM Media Group sp. z o.o in Acta Haematologica Polonica
- Vol. 51 (3) , 164-171
Open AccessAcute non-hematological toxicity of intensive chemotherapy of acute lymphoblastic leukemia in children
Introduction: Leukemia belong to 31% of all childhood malignancies. Acute lymphoblastic leukemia (ALL) is the most frequent type of pediatric leukemia accounting for 80–85% of all cases. Progress in diagnostics and therapy of leukemia is dependent on international cooperation. The objective of the study was the analysis of non-hematological toxicity during intensive chemotherapy according to two consecutive intercontinental protocols.Patients and methods: A total number of 210 children diagnosed for ALL who were treated in single center between 2002 and 2018 were divided in two groups defined by therapeutic protocol: ALL IC-BFM 2002 (group 1) and ALL IC-BFM 2009 (group 2). Data were entered prospectively from 2002 into international ALL IC-BFM 2002 and ALL IC-BFM 2009 registry. Non-hematological toxicity was analyzed according to the criteria followed in protocols, compatible with CTCAE criteria.Results: The most frequent toxicities included hepatic toxicity with transaminitis and hyperbilirubinemia, infections, oral mucositis and gut toxicity with vomiting, and/or diarrhea. Non-hematological toxicity episodes calculated as a ratio per patient were comparably often observed in both the groups; however, the distribution was different. There were more grade III and less grade II toxicities. This was mainly related to significant increase in the rates of infections and transaminitis. However, there was a significant decrease in vomiting and central and peripheral neurotoxicity.Conclusions: Intensive treatment of ALL is burdened with frequent severe toxic and infectious complications. Further progress in therapy of pediatric ALL is dependent on sophisticated supportive therapy and very well experienced and knowledgeable therapeutic team.